Global heart valve study seeks to uncover hidden differences in patients before treatment
NCT ID NCT07258706
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study enrolls 800 people with severe aortic stenosis who are scheduled for a TAVI procedure (a less invasive heart valve replacement). Researchers will compare participants from different countries using CT scans of the heart and blood tests to measure inflammation. The goal is to understand how anatomy and lab results vary across populations, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital, Ankara, Türkiye
Ankara, Turkey (Türkiye)
-
Institute for Cardiovascular Diseases of Vojvodina, Serbia University of Novi Sad
Novi Sad, Serbia
-
King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Bangkok, Thailand
-
Poznan University of Medical Sciences
Poznan, 61-848, Poland
-
San Bortolo's Hospital, Division of Cardiac Surgery and Division of Cardiology, Vicenza, Italy
Vicenza, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Grape powder may help aging immune systems — a trial puts it to the test
- AI ultrasound could unmask silent heart disease in seniors
- Hidden heart condition may affect aortic stenosis outcomes – can imaging catch it?
- A simple blood pressure cuff trick could shield the heart in kidney disease